The importance of CD138 shedding in various cancers/hematological malignancies is well documented (19, 33, 140), including in MM cells and within dysfunctional BMME, and unfortunately associated with poor prognosis, treatment and overall survival once its serum level increases in advanced-stage disease (116, 141–145). This evidence concerns the gene SDC1 and Miyoshi myopathy.